OUTLOOK THERAPEUTICS, INC. Cost of Revenue
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Cost of Revenue of $16.96 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-18
- OUTLOOK THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $16.96K, a 96.14% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $149.33K.
- OUTLOOK THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $29.63K.
- OUTLOOK THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $916.51K.
- OUTLOOK THERAPEUTICS, INC. cost of goods and services sold for fiscal 2025 was $1.36M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.96K 10-Q · filed 2026-08-18 | $166.29K derived: sum of 2 quarters · filed 2026-08-18 | $195.92K 10-Q · filed 2026-08-18 | $1.11M derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-03-31 | $149.33K 10-Q · filed 2026-05-15 | $178.95K 10-Q · filed 2026-05-15 | $1.10M derived: sum of 3 quarters · filed 2026-05-15 | $1.54M derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-12-31 | $29.63K 10-Q · filed 2026-02-17 | $946.14K derived: sum of 2 quarters · filed 2026-02-17 | $1.39M derived: sum of 3 quarters · filed 2026-08-18 | |
| 2025-09-30 | $916.51K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | $1.36M derived: sum of 2 quarters · filed 2026-08-18 | $1.36M 10-K · filed 2025-12-19 | |
| 2025-06-30 | $439.81K 10-Q · filed 2026-08-18 | $439.81K 10-Q · filed 2026-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |